Home » Newsletters » BioWorld

BioWorld

Jan. 11, 1994

View Archived Issues

THERATECH FILES INDS

CEPHALON FILES FOR PUBLIC OFFERING

ALEXIN COMPLETES THIRD VENTURE ROUND

ANTIBODY REVERSES DIABETES IN FRENCH MICE

SEPRACOR TO DEVELOP SINGLE-ISOMER DRUG FOR ALZA PATCH

GENPHARM'S BULL PRODUCES TRANSGENIC OFFSPRING

CHIRON, CEPHALON TEAM FOR NEUROLOGICAL DRUGS

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.